These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo. Holland JP; Divilov V; Bander NH; Smith-Jones PM; Larson SM; Lewis JS J Nucl Med; 2010 Aug; 51(8):1293-300. PubMed ID: 20660376 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging of multiple myeloma. Ma J; Zhang S; Yang N; Shang J; Gao X; Chen J; Wei H; Li Y; Zeng H; Xu H; Wang J; Liang SH; Wang R; Hu K; Wang L Eur J Nucl Med Mol Imaging; 2024 Sep; ():. PubMed ID: 39259226 [TBL] [Abstract][Full Text] [Related]
5. Preclinical ImmunoPET Imaging Using a Zr-89-Labeled Anti-CD146 Monoclonal Antibody for Diagnosis of Melanoma. Guo X; Hu M; Zhang Q; Liu J; Shi J; Tang Y; Liu S; Guo J; Kong Y; Zhu H; Yang Z Mol Pharm; 2024 Sep; 21(9):4490-4497. PubMed ID: 39077827 [TBL] [Abstract][Full Text] [Related]
7. A radiopharmaceutical [ Tang Y; Hu Y; Liu W; Chen L; Zhao Y; Ma H; Yang J; Yang Y; Liao J; Cai J; Chen Y; Liu N Nucl Med Biol; 2019 Mar; 70():23-31. PubMed ID: 30826708 [TBL] [Abstract][Full Text] [Related]
9. Site-Specific Photoaffinity Bioconjugation for the Creation of Delaney S; Nagy Á; Karlström AE; Zeglis BM Mol Imaging Biol; 2023 Dec; 25(6):1104-1114. PubMed ID: 37052759 [TBL] [Abstract][Full Text] [Related]
10. Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab. Holland JP; Caldas-Lopes E; Divilov V; Longo VA; Taldone T; Zatorska D; Chiosis G; Lewis JS PLoS One; 2010 Jan; 5(1):e8859. PubMed ID: 20111600 [TBL] [Abstract][Full Text] [Related]
11. Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for Raavé R; Sandker G; Adumeau P; Jacobsen CB; Mangin F; Meyer M; Moreau M; Bernhard C; Da Costa L; Dubois A; Goncalves V; Gustafsson M; Rijpkema M; Boerman O; Chambron JC; Heskamp S; Denat F Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1966-1977. PubMed ID: 31161258 [TBL] [Abstract][Full Text] [Related]
12. Cadherin-17 as a target for the immunoPET of adenocarcinoma. Delaney S; Keinänen O; Lam D; Wolfe AL; Hamakubo T; Zeglis BM Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2547-2557. PubMed ID: 38625402 [TBL] [Abstract][Full Text] [Related]
13. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing Cho H; Al-Saden N; Lam H; Möbus J; Reilly RM; Winnik MA Nucl Med Biol; 2020; 84-85():11-19. PubMed ID: 31931305 [TBL] [Abstract][Full Text] [Related]
14. Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44. Diebolder P; Mpoy C; Scott J; Huynh TT; Fields R; Spitzer D; Bandara N; Rogers BE J Nucl Med; 2021 Jan; 62(1):137-143. PubMed ID: 32513906 [TBL] [Abstract][Full Text] [Related]
15. Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer. Parent EE; Gleba JJ; Knight JA; Kenderian SJ; Copland JA; Cai H Mol Imaging Biol; 2024 Oct; 26(5):847-857. PubMed ID: 39174789 [TBL] [Abstract][Full Text] [Related]
16. Development of [ Ghai A; Zheleznyak A; Mixdorf M; O'Neal J; Ritchey J; Rettig M; DiPersio J; Shokeen M; Achilefu S Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1302-1311. PubMed ID: 33179150 [TBL] [Abstract][Full Text] [Related]
17. Efficient PD-L1 imaging of murine glioblastoma with FUS-aided immunoPET by leveraging FcRn-antibody interaction. Chevaleyre C; Novell A; Tournier N; Dauba A; Dubois S; Kereselidze D; Selingue E; Jego B; Maillère B; Larrat B; Nozach H; Truillet C Theranostics; 2023; 13(15):5584-5596. PubMed ID: 37908736 [No Abstract] [Full Text] [Related]
18. ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer. Chen W; Li M; Younis MH; Barnhart TE; Jiang D; Sun T; Lang JM; Engle JW; Zhou M; Cai W Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):861-870. PubMed ID: 34519889 [TBL] [Abstract][Full Text] [Related]
19. Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET. Wang S; Li J; Hua J; Su Y; Beckford-Vera DR; Zhao W; Jayaraman M; Huynh TL; Zhao N; Wang YH; Huang Y; Qin F; Shen S; Gioeli D; Dreicer R; Sriram R; Egusa EA; Chou J; Feng FY; Aggarwal R; Evans MJ; Seo Y; Liu B; Flavell RR; He J Clin Cancer Res; 2021 Mar; 27(5):1305-1315. PubMed ID: 33293372 [TBL] [Abstract][Full Text] [Related]